Pharmacology of Antifungal and Antiviral Drugs
Like antibiotics (antimicrobials to treat infections caused by bacteria), antifungals and antivirals should be used judiciously. The medication should be matched to the causative infectious organism, and the lowest effective dose should be used for the shortest amount of time. This will avoid unnecessary adverse events, prevent drug-drug interactions, and mitigate the development of microbial resistance to the armamentarium of effective antifungals and antivirals.
The goal of this course is to assist healthcare professionals in keeping up to date with commonly used antifungal and antiviral drugs.
Like antibiotics (antimicrobials to treat infections caused by bacteria), antifungals and antivirals should be used judiciously. The medication should be matched to the causative infectious organism, and the lowest effective dose should be used for the shortest amount of time. This will avoid unnecessary adverse events, prevent drug-drug interactions, and mitigate the development of microbial resistance to the armamentarium of effective antifungals and antivirals. The goal of this course is to assist healthcare professionals in keeping up to date with commonly used antifungal and antiviral drugs.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-23-026-H01-P
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.50 Nursing Contact Hours after successfully completing this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.50 contact hours for participating in this course.
Bahamas Medical Council
Bahamas Medical Council (CEBroker Provider #50-290)
Physicians will receive 1.50 AMA PRA category 1 Credits™.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.50 contact hours for participating in this course.
Florida Board of Medicine
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.50 AMA PRA category 1 Credits™.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.50 contact hours.
Florida Physician Assistants
Florida Physician Assistants (CEBroker Provider #50-290)
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Georgia Composite Medical Board - Physician Assistants
Georgia Composite Medical Board - Physician Assistants (CEBroker Provider #50-290)
Kansas State Board of Nursing
Kansas State Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 1.50 AMA PRA category 1 Credits™.
Michigan Board of Medicine
Physicians will receive 1.50 AMA PRA category 1 Credits™.
Michigan Board of Nursing
Michigan Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Michigan Board of Pharmacy
Michigan Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.50 contact hours.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 1.50 AMA PRA category 1 Credits™.
New Hampshire Medical Society
New Hampshire Medical Society (CEBroker Provider #50-290)
Physicians will receive 1.50 AMA PRA category 1 Credits™.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
New Mexico Medical Board
Physicians will receive 1.50 AMA PRA category 1 Credits™.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 1.50 AMA PRA category 1 Credits™.
Oklahoma Board Of Medical Licensure And Supervision - Physician Assistants
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 1.50 AMA PRA category 1 Credits™
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Wyoming Board of Nursing
Wyoming Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Review classes of antifungal drugs as well as adverse effects.
Identify the role of antiviral drugs as well as their adverse effects.
Recall healthcare practice considerations for the administration and maintenance of antifungal and antiviral medications.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Antifungal Drugs
Overview
Azoles
Allylamines/Non-azoles
Antimetabolites
Polyenes
Echinocandins
Miscellaneous/Uncategorized Antifungals
Review
Summary
Section 3: Antiviral Drugs
Overview
Influenza Antivirals
Herpesvirus Antivirals
Hepatitis C Antivirals
Hepatitis B Antivirals
Review
Summary
Section 4: Conclusion
Course Summary
Course Contributors
Resources
References
Subject Matter Expert: Johnny J. Bethea, II, RPh
Johnny received a B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Injectable Medications, and Asthma Therapy Management. At Relias, Johnny serves as a Partner in Behavioral Health Solutions, where duties include serving on Clinical Analytics and Applications Team, developing algorithms to improve clinical outcomes, engineering clinical consultant, SME, writer, and editor. In addition, he has served on the Executive Board of Directors for CMHCs and other medical organizations, pharmacy manager, APPE Preceptor, and college of pharmacy dean’s advisory council.Writer: Andrea Powell, RN, BSN
Andrea Powell, RN, BSN is a SME writer for Relias with a focus on acute care. She has over 11 years of clinical nursing experience, spanning across multiple nursing specialties. Her primary focus has been in critical care, with an affinity to surgical nursing. She also has experience in intraoperative nursing and post-anesthesia care. Andrea has served as a clinical team leader, preceptor and charge nurse to colleagues throughout her nursing career. She has a passion for the education of healthcare professionals and an aspiration for excellence in the healthcare delivery system.
The target audience for this course is: Nurses; Pharmacists; Physician Assistants; Physicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
